Armed with new proof-of-concept data showing that its in vivo base-editing therapy BEAM-302 can correct the gene mutation in alpha-1 antitrypsin deficiency (AATD), Beam Therapeutics is seeking to ...

It has been around a year since Beam Therapeutics slashed its headcount and R&D programmes to focus mainly on a sickle cell disease candidate – and the biotech has now revealed the first data with the ...

Gene expression analysis is undergoing a profound transformation, driven by the rapid evolution of advanced omics technologies. From single-cell ...

If you work with AI tools every day like I do, you probably know this already: that most of them sound better on the landing page than they perform in real life. So instead of repackaging PR blurbs ...

What it does: Disables masking and content fusion entirely. Result: Colors in non-editing regions may change uncontrollably. python run_synthesis_sd3.py --no_mask --alpha 0.3 ... --src_prompt str ...